Ophthalmologists are struggling to obtain a biologic to treat macular degeneration, and some insurers are allegedly promoting off-label use of biosimilars for patients.

Valtruis, a newly launched portfolio company focused on value-based care, invested the most, with additional money from Cigna and Blue Shield of California, two Cricket Health customers.

The Colorado Regional Health Information Organization and Health Current in Arizona will now operate as a combined not-for-profit regional health information exchange dubbed Contexture.

Health insurers, drug manufacturers, physicians and patients spend at least $93.3 billion a year on managing drugs, most of which is borne by patients.